ArticleInternational journal of cancer2016
The genetic tumor background is an important determinant for heterogeneous MYCN-amplified neuroblastoma.
Dominik Bogen et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
20 papers cite it
this papercites it